SCHEMBL5046573

SCHEMBL5046573

CC1(C)COc2ccc(CO)cc2OC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.45
CYP3A4 P08684 4/20 0.44
CYP2D6 P10635 1/20 0.44
PDCD1 Q15116 3/20 0.43
CD274 Q9NZQ7 3/20 0.43
TAAR1 Q96RJ0 3/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
PDE5A O76074 1/20 0.39
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
MIF P14174 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL11863120 0.79 CYP3A4 (0.61) CYP3A4CYP2D6TAAR1SLC6A2SLC6A4
SCHEMBL695934 0.79 PDCD1 (0.57) CYP3A4CYP2D6PDCD1CD274TAAR1
SCHEMBL2873266 0.79 CYP3A4 (0.65) CYP3A4CYP2D6TAAR1SLC6A2SLC6A4
SCHEMBL49914 0.79 CYP3A4 (0.65) CYP3A4CYP2D6TAAR1SLC6A2SLC6A4
SCHEMBL20225729 0.79 PDCD1 (0.57) CYP3A4CYP2D6PDCD1CD274TAAR1
SCHEMBL29907219 0.79 CYP3A4 (0.65) CYP3A4CYP2D6TAAR1SLC6A2SLC6A4
Propane SCHEMBL7421324 0.78 CYP3A4 (0.59) CYP3A4CYP2D6TAAR1SLC6A2SLC6A4
SCHEMBL12490416 0.77 RARB (0.38) PDCD1CD274
SCHEMBL3550976 0.77 RARB (0.47) PDCD1CD274
Methoxymethane SCHEMBL28541105 0.76 CYP3A4 (0.58) CYP3A4CYP2D6TAAR1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100439357-C Benzo [b][1,4] dioxepine derivatives HOFFMANN LA ROCHE (CH) 2008-12-03 CN disclosed
US-7459480-B2 Benzodioxepine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-12-02 US disclosed
US-7459480-B2 Benzodioxepine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-12-02 US disclosed
US-7459480-B2 Benzodioxepine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-12-02 US disclosed
EP-1682528-B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-09-12 EP disclosed
EP-1682528-B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-09-12 EP disclosed
CN-1875015-A Benzo [b][1,4] dioxepine derivatives HOFFMANN LA ROCHE (CH) 2006-12-06 CN disclosed
EP-1682528-A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-07-26 EP disclosed
US-20050113374-A1 Benzodioxepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-05-26 US disclosed
WO-2005044814-A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113374-A1 Benzodioxepine derivatives BBOX1, ACOX1, ACOX3 ACACB 5/4885CYP3A4 84/4885CYP2D6 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.